Subscribe to RSS
DOI: 10.1055/s-0038-1651641
Beta-Lactam Antibiotics Inhibit Agonist-Stimulated Platelet Calcium Influx
Publication History
Received 28 October 1991
Accepted after revision 04 January 1993
Publication Date:
25 July 2018 (online)
Summary
(β-lactam antibiotics cause platelet dysfunction with reversible agonist-receptor inhibition, irreversible [14C]-penicillin binding, and inhibition of agonist-stimulated elevation in cytosolic Ca2+ ([Ca2+]i), occurring after 24 h exposure in vitro and after in vivo treatment. We investigated β-lactam antibiotic-induced inhibition of rises in [Ca2+]i stimulated by thrombin, sodium arachidonate or A23187 to determine whether Ca2+ influx or intracellular release was primarily affected. The mean rise in [Ca2+]i, measured with fura-2-AM, was inhibited 43.7-84.1% by penicillin when the extracellular Ca2+ concentration ([Ca2+]e) was 1 mM, but was significantly less inhibited when [Ca2+]e was <1 μM. NiCl2 (2 mM), that blocks Ca2+ influx, caused inhibition comparable to penicillin. MnCl2 (1 mM), that quenches the intracellular fura-2 signal, significantly decreased the rise in 1 mM [Ca2+]i when [Ca2+]e was 1 mM, but did not increase the inhibition caused by penicillin. Penicillin did not inhibit the rise in [Ca2+]i stimulated by inositol-1,4,5-trisphosphate or GTPγS. Therefore, β-lactam antibiotics inhibit agonist-induced elevations of [Ca2+]i primarily through inhibition of Ca2+ influx, which probably accounts for the irreversible inhibition of platelet function seen after prolonged in vitro or in vivo treatment.
-
References
- 1 Shattil SJ, Bennett JS, McDonough M, Turnbull J. Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J Clin Invest 1980; 65: 329-337
- 2 Burroughs SF, Johnson GJ. β-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin. Blood 1990; 75: 1473-1480
- 3 Brown III CH, Natelson EA, Bradshaw MW, Williams Jr TW, Alfrey Jr. CP. The hemostatic defect produced by carbenicillin. N Engl J Med 1974; 291: 265-270
- 4 Johnson GJ, Rao GHR, White JG. Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Am J Pathol 1978; 91: 85-105
- 5 Berridge MJ. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem 1987; 56: 159-194
- 6 Brass LF, Shattil SJ. Identification and function of high affinity binding sites for Ca2+ on the surface of platelets. J Clin Invest 1984; 73: 626-632
- 7 Hallam TJ, Rink TF. Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett 1985; 156: 175-179
- 8 Rink TJ, Smith SW, Tsien RY. Cytoplasmic free Ca2+ thresholds and Ca-independent activation for shape change and secretion. FEBS Lett 1982; 148: 21-26
- 9 Hashimoto Y, Ogihara A, Nakanishi S, Matsuda Y, Kurokawa K, Nonmura Y. Two thrombin-activated Ca2+ channels in human platelets. J Biol Chem 1992; 267: 17078-17081
- 10 Fine KM, Ashbrook PC, Brigden LP, Maldonado JE, Didisheim P. Gel-filtered human platelets. Ultrastructure, function, and the role of proteins in inhibition of aggregation by aspirin. Am J Pathol 1976; 84: 11-24
- 11 Johnson GJ, Leis LA, Rao GHR, White JF. Arachidonate-induced platelet aggregation in the dog. Thromb Res 1979; 14: 147-154
- 12 Born GTR, Cross MJ. The aggregation of human platelets. J Physiol 1963; 168: 178-195
- 13 Johnson GJ, Dunlop PC, Leis LA. From AHL. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2/prostaglandin H2 receptor. Circ Res 1988; 62: 494-505
- 14 Fujimoto T, Fujimura K, Kuramoto A. Electrophysiological evidence that glycoprotein IIb/IIIa complex is involved in calcium channel activation on human platelet plasma membrane. J Biol Chem 1991; 266: 16370-16375
- 15 Zschauer A, van Breenan C, Buhler F, Nelson M. Calcium channels in thrombin-activated human platelet membrane. Nature 1988; 334: 703-705
- 16 Mahaut-Smith M, Sage SO, Rink TJ. Receptor-activated single channels in intact human platelets. J Biol Chem 1990; 265: 10479-10483
- 17 Hashimoto Y, Ogihara A, Nakanishi S, Matsuda Y, Kurokawa K, Nonomura Y. Two thrombin-activated Ca2+ channels in human platelets. J Biol Chem 1992; 267: 17078-17081
- 18 Brass LF. Ca2+ transport across the platelet plasma membrane. A role for membrane glycoproteins IIb and IIIa. J Biol Chem 1985; 260: 2231-2236
- 19 Rybak ME, Renzulli LA, Bruns MJ, Cahaly DP. Platelet glycoproteins IIb and IIIa as a calcium channel in liposomes. Blood 1988; 72: 714-720
- 20 Rybak MEM, Renzulli LA. Ligand inhibition of the platelet glycoprotein IIb-IIIa complex function as a calcium channel in liposomes. J Biol Chem 1989; 264: 14617-14620
- 21 Powling MJ, Hardisty RM. Glycoprotein IIb-IIIa complex and Ca2+ influx into stimulated platelets. Blood 1985; 66: 731-734
- 22 Yamaguchi A, Yamamoto N, Kitagawa H, Tanoue K, Yamazaki H. Ca2+ influx mediated through the GPIIb/IIIa complex during platelet activation. FEBS Lett 1987; 225: 228-232
- 23 Ware JA, Decenzo MT, Smith M, Saitoh M. Calcium mobilization and glycoprotein IIb-IIIa complex ligands in epinephrine-stimulated platelets. Am J Physiol 1991; 260: H1619-H1624
- 24 Sinigaglia F, Bisio A, Torti M, Balduini C, Bertolino G, Balduini C. Effect of GPIIb-IIIa complex ligands on calcium ion movement and cytoskeleton organization in activated platelets. Biochem Biophys Res Commun 1988; 154: 258-264
- 25 Kaibuchi K, Takai Y, Sawamura M, Hoshijima M, Fujikura T, Nishizuka Y. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem 1983; 258: 6701-6704